| scholarly article | Q13442814 |
| P50 | author | Nassim Kamar | Q49264830 |
| Céline Guilbeau-Frugier | Q66360670 | ||
| Lionel Rostaing | Q66732955 | ||
| Marylise Fort | Q117263238 | ||
| P2093 | author name string | Louiza Mekhlati | |
| P2860 | cites work | Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause | Q43580802 |
| P433 | issue | 9 | |
| P921 | main subject | transplant glomerulopathy | Q16258703 |
| P304 | page(s) | 906-913 | |
| P577 | publication date | 2009-05-15 | |
| P1433 | published in | Transplant International | Q15762140 |
| P1476 | title | Treatment of symptomatic transplant glomerulopathy with rituximab. | |
| P478 | volume | 22 |
| Q37529483 | Can a combined screening/treatment programme prevent premature failure of renal transplants due to chronic rejection in patients with HLA antibodies: study protocol for the multicentre randomised controlled OuTSMART trial |
| Q26829790 | Complement cascade and kidney transplantation: The rediscovery of an ancient enemy |
| Q48955987 | De Novo Donor-Specific Human Leukocyte Antigen Antibody Screening in Kidney Transplant Recipients After the First Year Posttransplantation: A Medical Decision Analysis |
| Q58805821 | Drug-Induced Hematological Cytopenia in Kidney Transplantation and the Challenges It Poses for Kidney Transplant Physicians |
| Q89965614 | Effect of Optimized Immunosuppression (Including Rituximab) on Anti-Donor Alloresponses in Patients With Chronically Rejecting Renal Allografts |
| Q37601515 | Graft dysfunction in chronic antibody-mediated rejection correlates with B-cell-dependent indirect antidonor alloresponses and autocrine regulation of interferon-γ production by Th1 cells. |
| Q51002006 | Intravenous immunoglobulins and rituximab therapy for severe transplant glomerulopathy in chronic antibody-mediated rejection: a pilot study. |
| Q39264020 | Invasive fungal infections in paediatric patients treated with macromolecular immunomodulators other than tumour necrosis alpha inhibitors. |
| Q40149564 | Long-term graft survival in patients with chronic antibody-mediated rejection with persistent peritubular capillaritis treated with intravenous immunoglobulin and rituximab. |
| Q27026434 | Rituximab in renal transplantation |
| Q37670308 | Rituximab treatment prevents the early development of proteinuria following pig-to-baboon xeno-kidney transplantation. |
| Q57474736 | Rituximab, plasma exchange and immunoglobulins: an ineffective treatment for chronic active antibody-mediated rejection |
| Q50063069 | Transplant glomerulopathy |
| Q38205229 | Transplant glomerulopathy: the interaction of HLA antibodies and endothelium |
| Q65000602 | Treatment with intravenous immunoglobulins and methylprednisolone may significantly decrease loss of renal function in chronic-active antibody-mediated rejection. |
| Q58754949 | Treatment with plasmapheresis, immunoglobulins and rituximab for chronic-active antibody-mediated rejection in kidney transplantation: Clinical, immunological and pathological results |
Search more.